drugset / Trial / NCT06586658
Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells
Phase 0
Recruiting
9 enrolled
Shanghai Changzheng Hospital
Shanghai First Song Biotechnology Co., LTD · collab
NaSingle-groupOpen-labelTreatment
Summary
This is an investigator-initiated trial to evaluate the role of anti-CD70-CAR T cells in locally advanced or recurrent/metastatic renal cell carcinoma that is inoperable.
Timeline
- Start
- 2024-09-06
- Primary completion
- 2027-07-16
- Completion
- 2027-07-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anti-CD70 CAR-T cells | Cell therapy | 3e+06 cells/kg | Intravenous |
| Subject | Anti-CD70 CAR-T cells | Cell therapy | 1e+07 cells/kg | Intravenous |
| Subject | Anti-CD70 CAR-T cells | Cell therapy | 2e+07 cells/kg | Intravenous |